Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate for Doxorubicin-Induced Cardiotoxicity in Breast Cancer
NCT06155331Phase 2Completed
- Sponsor
- Tanta University
- Start
- Dec 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenofibrate in Cardiotoxicity, sponsored by Tanta University. Started Dec 2023; status: completed.
02
Drugs
fenofibrate
03
Conditions
Cardiotoxicity
Beyond the preview
Go deeper on NCT06155331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06155331.